Editorial
Cardiac destination therapy in pediatrics – Are we there yet?
Chet R. Villa MD,
Chet R. Villa MD
The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA
Search for more papers by this author Angela Lorts MD,
Angela Lorts MD
The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA
Search for more papers by this author
Chet R. Villa MD,
Chet R. Villa MD
The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA
Search for more papers by this author Angela Lorts MD,
Angela Lorts MD
The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA
Search for more papers by this author
First published: 25 July 2016
No abstract is available for this article.
References
- 1Blume ED, Rosenthal DN, Rossano JW, et al. Outcomes of children implanted with ventricular assist devices in the United States: First analysis of the Pediatric Interagency Registry for Mechanical Circulatory Support (PediMACS). J Heart Lung Transplant 2016: 35: 578–584.
- 2Rossano JW, Lorts A, Vanderpluym CJ, et al. Outcomes of pediatric patients supported with continuous-flow ventricular assist devices: A report from the Pediatric Interagency Registry for Mechanical Circulatory Support (PediMACS). J Heart Lung Transplant 2016: 35: 585–590.
- 3Schweiger M, Vanderpluym C, Jeewa A, et al. Outpatient management of intra-corporeal left ventricular assist device system in children: A multi-center experience. Am J Transplant 2015: 15: 453–460.
- 4Char DS, Lee SS, Ikoku AA, et al. Pediatric transplantation. Can destination therapy be implemented in children with heart failure? A study of provider perceptions. Pediatr Transplant 2016.
- 5Ryan TD, Jefferies JL, Sawnani H, et al. Implantation of the HeartMate II and HeartWare left ventricular assist devices in patients with duchenne muscular dystrophy: Lessons learned from the first applications. ASAIO J 2014: 60: 246–248.
- 6Strueber M, Larbalestier R, Jansz P, et al. Results of the post-market Registry to Evaluate the HeartWare Left Ventricular Assist System (ReVOLVE). J Heart Lung Transplant 2014: 33: 486–491.
- 7Pagani FD, Milano CA, Tatooles AJ, et al. HeartWare HVAD for the treatment of patients with advanced heart failure ineligible for cardiac transplantation: Results of the ENDURANCE destination therapy trial. J Heart Lung Transplant 2015: 34: S9.
- 8Kirklin JK, Naftel DC, Pagani FD, et al. Seventh INTERMACS annual report: 15,000 patients and counting. J Heart Lung Transplant 2015: 34: 1495–1504.
